BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36917897)

  • 1. Integrated genetic profiling of archival pediatric high-grade glial tumors and reassessment with 2021 WHO classification of paediatric CNS tumours.
    Cooley LD; Lansdon LA; Laurence K; Herriges JC; Zhang L; Repnikova EA; Joyce J; Thakor P; Warren L; Smith SC; Yoo B; Gener M; Ginn KF; Farooqi MS
    Cancer Genet; 2023 Jun; 274-275():10-20. PubMed ID: 36917897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
    Thomas DL
    Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification].
    Figarella-Branger D; Chappe C; Padovani L; Mercurio S; Colin C; Forest F; Bouvier C
    Bull Cancer; 2013; 100(7-8):715-26. PubMed ID: 23831947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
    Perez A; Huse JT
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience.
    Colli SL; Cardoso N; Massone CA; Cores M; García Lombardi M; De Matteo EN; Lorenzetti MA; Preciado MV
    PLoS One; 2022; 17(4):e0266466. PubMed ID: 35363819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification.
    Gianno F; Giovannoni I; Cafferata B; Diomedi-Camassei F; Minasi S; Barresi S; Buttarelli FR; Alesi V; Cardoni A; Antonelli M; Puggioni C; Colafati GS; Carai A; Vinci M; Mastronuzzi A; Miele E; Alaggio R; Giangaspero F; Rossi S
    Pathologica; 2022 Dec; 114(6):422-435. PubMed ID: 36534421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [World Health Organization Classification of Central Nervous System Tumours, 5
    Ichimura K
    No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.
    Métais A; Bouchoucha Y; Kergrohen T; Dangouloff-Ros V; Maynadier X; Ajlil Y; Carton M; Yacoub W; Saffroy R; Figarella-Branger D; Uro-Coste E; Sevely A; Larrieu-Ciron D; Faisant M; Machet MC; Wahler E; Roux A; Benichi S; Beccaria K; Blauwblomme T; Boddaert N; Chrétien F; Doz F; Dufour C; Grill J; Debily MA; Varlet P; Tauziède-Espariat A
    Acta Neuropathol; 2023 Jan; 145(1):83-95. PubMed ID: 36264505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histomolecular diagnosis of glial and glioneuronal tumours].
    Métais A; Rousseau A
    Ann Pathol; 2021 Apr; 41(2):137-153. PubMed ID: 33712303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification / characterisation of low grade glioneuronal tumours.
    Dyke J; Calapre L; Beasley A; Gray E; Allcock R; Bentel J
    Pathol Res Pract; 2022 Jan; 229():153724. PubMed ID: 34942511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
    Weller M; Weber RG; Willscher E; Riehmer V; Hentschel B; Kreuz M; Felsberg J; Beyer U; Löffler-Wirth H; Kaulich K; Steinbach JP; Hartmann C; Gramatzki D; Schramm J; Westphal M; Schackert G; Simon M; Martens T; Boström J; Hagel C; Sabel M; Krex D; Tonn JC; Wick W; Noell S; Schlegel U; Radlwimmer B; Pietsch T; Loeffler M; von Deimling A; Binder H; Reifenberger G
    Acta Neuropathol; 2015 May; 129(5):679-93. PubMed ID: 25783747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse leptomeningeal glioneuronal tumor without KIAA1549-BRAF fusion and 1p detection: a case report and review of literature.
    Cheng W; He L; Zhu J; Fan X
    Childs Nerv Syst; 2022 Feb; 38(2):279-285. PubMed ID: 34977973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.
    Haque F; Varlet P; Puntonet J; Storer L; Bountali A; Rahman R; Grill J; Carcaboso AM; Jones C; Layfield R; Grundy RG
    Acta Neuropathol Commun; 2017 Jun; 5(1):45. PubMed ID: 28587626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput microRNA profiling of pediatric high-grade gliomas.
    Miele E; Buttarelli FR; Arcella A; Begalli F; Garg N; Silvano M; Po A; Baldi C; Carissimo G; Antonelli M; Spinelli GP; Capalbo C; Donofrio V; Morra I; Nozza P; Gulino A; Giangaspero F; Ferretti E
    Neuro Oncol; 2014 Jan; 16(2):228-40. PubMed ID: 24305714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
    Hu W; Duan H; Zhong S; Zeng J; Mou Y
    J Transl Med; 2022 Feb; 20(1):64. PubMed ID: 35109850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.
    Pallavajjala A; Haley L; Stinnett V; Adams E; Pallavajjala R; Huang J; Morsberger L; Hardy M; Long P; Gocke CD; Eshleman JR; Rodriguez FJ; Zou YS
    Hum Pathol; 2022 Aug; 126():63-76. PubMed ID: 35561840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.